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Abstract 
The lack of a commercial laboratory, pilot and small manufacturing scale dead end continuous filtration and drying 
unit it is a significant gap in the development of continuous pharmaceutical manufacturing processes for new APIs 
(Active Pharmaceutical Ingredients). To move small-scale pharmaceutical isolation forward from traditional batch 
Nutsche filtration to continuous processing a continuous filter dryer prototype unit (CFD20) was developed in 
collaboration with Alconbury Weston Ltd (AWL). The performance of the prototype was evaluated by 
comparison with manual best practice exemplified using a modified Biotage VacMaster unit to gather data and 
process understanding for API filtration and washing. The ultimate objective was to link the chemical and physical 
attributes of an API slurry with equipment and processing parameters to improve API isolation processes. 
Filtration performance was characterised by assessing filtrate flow rate by application of Darcy’s law, the impact 
on product crystal size distribution and product purity were investigated using classical analytical methods. The 
overall performance of the two units was similar, showing that the prototype CFD20 can match best manual lab 
practice for filtration and washing while allowing continuous processing and real-time data logging. This result is 
encouraging and the data gathered provides further insight to inform the development of CFD20. 
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Introduction 
Many of the world’s large pharmaceutical industries are considering moving from batch to continuous API 
manufacture to reduce cost of production, to increase manufacturing flexibility, to reduce plant size and to enhance 
control of API critical quality attributes during production1-3. In 2003 the United States Food and Drug 
Administration (FDA) set out to encourage companies to adopt innovative processing methods to improve product 
consistency.4-6 A number of innovations have been reported to move synthesis, crystallization and secondary 
processes from batch to continuous operation. However, both API, and intermediate isolations are almost 
exclusively performed batch wise. According to Murugesan et al 7, typical industrial practice is to wash a filter 
cake with at least three cake volumes of solvent, which approximates to between 5 and 7 mL of solvent per gram 
of API produced. Improving wash efficiency would improve environmental performance and product purity and 
reduce manufacturing costs and solvent use. 
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Few examples of small-scale continuous isolation equipment have been commercialized. The Steadfast rotary 
drum filter is a cross-flow isolation unit principally designed for clarification of suspensions from bioprocessing 
where the desired product is in the solution phase and the solid phase is a waste stream. The capacity is around 3 
litres per minute of slurry.8-9 In 2010, researchers at MIT developed a small-scale continuous Linear Motion 
Pharmaceutical Filtration Module, which ran for 250 hours and was capable of processing 1 L of mother liquor 
per hour, corresponding to 100g of API per hour.10 In 2011 researchers at Pfizer proposed a new filter and dryer 
prototype, which they termed the D&M continuous filter and dryer. It filters small aliquots of slurry (15-30 mL 
per aliquot), using a 3-way valve. The Pfizer prototype was able to process approximately 1g of filter cake per 
minute or 1.4 kg/day.11 Moving to large-scale continuous isolation units; in 2015 BHS marketed a Continuous 
Indexing Vacuum Belt filter. This comprised a vacuum filter with either co- or counter-current washing also with 
vacuum, it also has convection, pressing and steam drying capabilities, and is reported to filter cake of 5 to 150 
mm in thickness and process up to 85 kg/hr of solid crystalline material with cake moisture target of 45%.12 
None of the commercial or prototype continuous isolation units combine dead end filtration(1) with washing and 
drying capabilities. The REMEDIES project13 aims to address this gap in collaboration with Alconbury Weston 
Ltd (AWL) by developing a dead end isolation unit which can operate from lab scale to small scale manufacture. 
The unit performs filtration, washing and drying in a fully automated, semi-continuous manner. The unit may be 
coupled with a continuous upstream process and can be located in a laboratory fume hood.  
The target is to reduce processing time and cost whilst minimising negative impacts on API particle physical 
properties in order to deliver API that is optimal for final processing into drug products. 
 Typically the critical quality attributes to be established during the isolation of active pharmaceutical compounds 
are purity and particle size distribution. Both are achieved principally by the upstream process of crystallization 
in which particles of the required size and purity are generated in suspension in impure mother liquors. Filtration, 
washing and drying steps are needed to isolate API without dissolving, breaking or granulating the crystals or 
precipitating dissolved product or impurities. 
Multiple chemical, physical and technological factors affect filtration: the feed suspension viscosity, particle size 
distribution, and the interaction between solvents and particles affect filtration rate, ease of washing and 
propensity for filter blockage.14-18 
Equipment design affects filtration performance. The size and geometry of the filtration chamber and the slurry 
feed system should favour the formation of a uniform cake whilst minimising wall effects.19 The filter medium 
should retain product particles whilst maximising solution flow. Media clogging caused by particle retention and 
the build-up of a consolidated heel potentially become problems during extended continuous operation.14 
Without effective washing, impurities which are in solution in any filtrate which is retained in the filter cake are 
incorporated in the product during drying. Any dissolved solute is also deposited and tends to promote granulation, 
changing the product particle size distribution. A washing step is usually employed to minimise these problems.20  
In order to determine how the AWL CFD20 prototype addresses the challenges outlined above and to determine 
filtration and washing performance a set of experiments were designed and performed to compare the prototype 
with manual best practise using the modified Biotage VacMaster unit: 
a) Select test materials and characterise their key attributes. 
b) Perform filtration and washing experiments using manual lab best practice to establish a performance 
base line and to identify operational challenges which a filtration and washing system must address. 
c) Conduct tests on the evolving prototype system, evaluating the performance of each sub-operation, either 
confirming success or identifying items requiring further improvement. 
                                                          
(1) Dead end filtration is the most common method of filtration where the slurry, with known composition is placed in a chamber, with filter 
medium at the base, a pressure difference is established across the medium to drive  the liquid phase through the  medium. Consequently a 
cake of solid particles is formed on the top of the medium as the filtrate passes through and its thickness increases with time until eventually 
the filter cake is harvested. Cross flow filtration is the other method of filtration. Cross flow filtration is a technique for increasing the solids 
loading of a slurry by taking off a particle free stream. Typical cross flow filters comprise an inner filter encapsulated in an outer cylinder. 
The thickening process starts when slurry is convoyed into the outer cylinder the rate of flow from the source vessel is sufficient that there is 
always an overflow back to the source vessel and the flow keeps the particles suspended. A pressure difference is established between the core 
of the filter and the outer annular region, this causes filtrate to flow through the medium to be collected as clarified filtrate leading to an 
increase in the solids loading of the circulating slurry. 
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d) Confirm process understanding of how chemical and physical properties of the API slurries interact with 
process parameters as a basis for designing and improving API isolation processes. 
The success criteria used to compare the AWL CFD20 prototype’s performance with manual best practice 
exemplified in the Biotage VacMaster unit were: 
a) Achieve comparable or better purity than can be achieved using Biotage unit; 
b) Maintain the PSD of the input particles; 
c) Translate the simplicity of process operation and flexibility of the Biotage unit to an automated 
continuous isolation unit (for example offering the capability to halt filtration at dry land2 or 
breakthrough). 
The CFD20 was used in optimisation mode to process one slurry aliquot per time and be able to collect for each 
experiment filtrates and cake samples.  
The aim of this part of the project was to determine if the CFD20 could perform in a similar way to the best 
practise manual unit. Using the results gathered from these experiments the prototype will be further developed 
to improve the unit’s operability and process robustness. In future, the unit will be tested with more challenging 
material to understand the efficiency of the CFD20 to reduce time required to develop API isolation strategies 
using a DOE approach. In addition the unit will be tested in production mode to evaluate the capability of the 
system to operate for an extended period and produce consistent isolated dried cakes. 
Methods 
Paracetamol was selected as a representative test compound with characteristics typical of APIs. It is commercially 
available, as are its impurities of synthesis. Two extremes of size distribution (granular and micronized) were 
selected to challenge different aspects of filtration, washing and drying. The granular material (Mallinckrodt Inc., 
Staines-upon-Thames, UK, batch 161713J561) represents a challenge for uniform particle suspension and transfer 
into the filter and exhibits very rapid settling and filtration. The micronized material (Mallinckrodt, Inc., batch 
042213E407) settles and filters slowly, has a large wetted surface area to wash and is more challenging to dry 
than the granular material. 
Wash performance and cake purity were evaluated using a solvent soluble dye, Patent Blue V sodium salt (Sigma 
Aldrich, LOT: BCBP1872V). The dye aids visualisation of the filtration and washing process as well as being 
readily quantified spectroscopically.  
Ethanol (Absolute, ≥99.8%, Sigma Aldrich) was used to create the feed suspension; it is widely used as 
crystallization solvent. Millipure water was selected as wash solvent due to paracetamol’s relatively low aqueous 
solubility and because Patent Blue V dye is very soluble in in water, as reported by Newton et al.21 
 
Material characterisation suspension and wash preparation 
Granular and micronized paracetamol were characterized by measuring true and tapped density, particle size 
distribution (PSD) and particle morphology. Tapped density was repeated 4 times using the autotap and following 
the International Pharmacopeia procedure 22. Both samples were confirmed to be polymorphic form I by Powder 
X-ray diffraction. The solubility of paracetamol in ethanol and water was taken from the literature23, compared 
with predictions made using COSMOTherm, and confirmed experimentally. An appropriate concentration of 
Patent Blue V dye was selected based on its absorbance maximum determined using UV-vis spectrometry. 
Paracetamol particle suspensions were prepared by dissolving Patent Blue V dye in ethanol at a concentration of 
28.6 mg/L. Paracetamol was then added in two portions; the first to dissolve and form a saturated ethanolic 
solution at 20°C, the second to remain undissolved with minimal change to the particle size distribution. The 
                                                          
2 Halting a filtration at dry land is a widely practiced procedure where filtration is stopped when liquid level above the cake reaches the cake 
surface This procedure is recommended to maintain a an undamaged, fully saturated filter cake as the ideal starting point for washing. The 
alternative practice of deliquoring the cake prior to washing  leads to cake cracking which creates a low resistance path for the wash solvent 
leading to less effective removal of mother liquour  during filtration. The practice of deliquoring the cake is commonly known as breakthrough. 
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combined paracetamol mass per 50 mL aliquot of ethanol was 19.34 g which resulted in a 49% solids loading by 
mass. Wash solvent was produced by preparing a solution of paracetamol in water which was saturated at 10°C 
to form a slightly undersaturated wash solution at 20°C. Mother liquor density and viscosity were measured and 
compared with pure ethanol values.24 
 
Biotage manual filtration system overview 
A modified Biotage VacMaster was used to filter and wash the paracetamol suspensions using manual best 
practice 25. The rack inside the filter chamber was modified to accommodate 50 mL graduated cylinders, the valve 
assembly on the chamber lid comprised a pair of PTFE valves. One valve remained with the filter tube to prevent 
leakage during transfer and weighing steps, the other prevented ingress of air when the filter tube was removed. 
The pressure driving force was controlled using a Buchi V850 vacuum controller. 
Biotage ISOLUTE 70mL double fritted polypropylene reservoirs with 20µm pore size were used to filter, wash 
and deliquor the cake. The pre-weighed filter tube was connected to the PTFE valves on top of the tank. Inside 
the tank pre-weighed glass graduated cylinders were positioned to collect filtrate, wash liquors and final 
deliquoring residue prior to drying.  
A new filter tube was used for each experiment. 50 mL of sample slurry was transferred to the filter tube and if 
necessary some liquor was transferred back to the slurry vessel to allow rinsing to achieve as complete a slurry 
transfer as possible. When the selected vacuum was reached inside the glass tank, the valve below the filter tube 
was opened to allow filtrate to flow through the medium into the graduated cylinder. On reaching dry land, or if 
specified breakthrough, both PTFE valves were closed. The filter tube and the upper PTFE valve were removed 
and the mass of tube and filter cake was measured along with the filter cake thickness. The tube was then placed 
on the next valve on the top of the filter chamber in preparation for washing. 
The required quantity of wash solvent was transferred to the top of the cake by slowly running the wash down the 
wall of the filter tube using a disposable pipette. Great care was taken to minimise disturbance of the filter cake 
surface and mixing of the clean wash liquor with the mother liquors in the cake. This procedure was repeated for 
each washing step, if more than one was required. The final wash was followed by cake deliquoring after which 
each of the collected filtrates was weighed, their volumes recorded and samples were taken to quantify the Patent 
Blue V dye spectroscopically. The operative procedure is fully described in the supporting information section. 
 
CFD20 continuous filtration, washing and drying system overview 
The CFD20 unit shown in Figure 1 allows filtration followed by up to four washing steps with two different 
solvents, deliquoring and drying. The unit is controlled through a touch-screen panel. Three different operating 
approaches can be used: fully manual, semi-automated, called ‘Optimisation Mode’, and fully continuous mode, 
called ‘Production Mode’. Manual mode is used when the operator requires full control of each step of isolation; 
this method uses the maximum available vacuum (900mbar) to filter the cake and as the camera cannot be used 
to halt filtration at dry land the operator must manually stop the filtration step. In addition, the operator may 
manually control wash quantity, wash solvent deliquoring and drying. Optimisation mode is used when cakes are 
processed one at a time: this mode is recommended for process development. To set filtration, washing and drying 
parameters a setup screen is used to program the unit. Production mode is fully automated and can simultaneously 
process a cake in each port and so isolate multiple aliquots of slurry, this mode is used once the process has been 
optimised and allows for maximum throughput. 
The key components are: an agitated slurry tank, a slurry transfer system and the filter carousel. The carousel 
contains ten identical open-ended glass tubes of inner diameter 20mm. These tubes rotate above a base with ten 
filter apertures, nine of which contain a BOPP Poremet 20 filter mesh.26 The filter chambers are formed when the 
carousel is compressed against the base plate with each glass tube located above a filter. The final position without 
a filter plate is used for product discharge. 
 The workflow described above using the Biotage unit was replicated as closely as possible in the CFD20 to allow 
comparison of the two systems. 
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Figure 1  CFD20 Carousel filtration unit. 
During operation, a selected volume of slurry was transferred into the first glass filter tube using a vacuum slurry 
transfer system. Filtration was performed at a set pressure by modulating a vacuum valve. Filtrate was collected 
in a receiver on a load-cell allowing the filtration rate to be logged. The filtration was either halted at dry land by 
a vision system on the CFD or allowed to continue to breakthrough by bypassing the automatic control and 
stopping the filtration manually. 
After filtration the carousel was rotated taking the filter cake along with it. Once in position above the second 
filter plate, the carousel was again compressed against the base plate to form a seal. This second position was then 
used for displacement washing. A set volume of solvent was dispensed onto the cake - using an atomizer that 
gently dispense the wash solvent on cake surface without disturbing the surface of the cake - and driven through 
the cake in a similar manner to the first filtration. So that the cake is washed by displacement washing. The wash 
liquid was collected in a separate receiver on a load cell. Separate receivers allowed samples of mother liquor and 
wash liquor to be recovered for analysis. 
After the filtration and washing steps were completed, the filter cake was thoroughly deliquored by applying 
vacuum for 300 seconds. The filter carousel was then rotated to its final position and a piston ejected the filter 
cake as product.  
 
Experimental design  
Five sets of experiments were performed using the Biotage and CFD20 units to evaluate their performance against 
two key filtration and washing success criteria:  
 Purity (API should be both chemical and phase pure with negligible residual solvent); 
 Particle size (no breakage, granulation, dissolution or fines precipitation). 
The volumes of wash solvent were selected to be a little less than one cake void volume (5 mL) and to be a little 
more than one cake void volume (10 mL) to study the effect of wash solvent volume in relation to purity achieved. 
6 
 
Two filtration end point approaches were evaluated; halting the process at dry land and continuing to 
breakthrough. Halting the process at dry land when the liquid interface reached the cake surface ensured that the 
cake remained fully saturated and established ideal conditions for displacement washing. Continuing filtration 
and washing to breakthrough minimised the mother liquor hold up in the cake but risked cake cracking establishing 
a low resistance path for subsequent wash solvent to pass through the cake unevenly limiting the effectiveness of 
washing.27 
Equivalent data was collected from both systems. In the case of Biotage, data collection was performed manually, 
recording the quantity of filtrate collected against time. The CFD20, controlled locally through a touchscreen HMI 
(Human Machine Interface) and PharmaMV software, was used to collect all the process data in real time. Final 
cake and filtrate mass were recorded manually by weighing each sample to verify the load cell data collected 
using Pharma MV. 
Biotage experiments 
 
Table 1 Experimental code. 
EXPERIMENT CODE MATERIAL 
2 and 4 Micronised (M) 
1 and 3 Special granular (SG) 
a No wash solvent 
b 1 * 5mL wash solvent 
c 1 * 10mL wash solvent 
d 2 * 5mL wash solvent 
e 2 * 10mL wash solvent 
 
Table 2 DOE fixed parameters and variables. 
FIXED PARAMETER VALUE 
Dose 50mL 
ΔP during filtration 800mbar 
ΔP during wash 1 800mbar 
ΔP during wash 2 800mbar 
Hold time before washing 60s 
VARIABLES VALUES 
Deliquor mode Dryland (exp 2) 
Breakthrough (exp 3 and 4) 
Wash mode Dryland (exp 2) 
Breakthrough (exp 3 and 4) 
 
The experiments set out in Table 1 were performed using the Biotage and CFD20 systems: 
For Biotage experiments separate 50 mL aliquots of slurry were prepared for each experiment to ensure a constant 
slurry solid loading. 
CFD20 experiments 
The CFD20 experiments were performed by automation in optimisation mode during the filtration step and in 
manual mode during washing and drying.  
CFD20 experiments 2a, b, c, d and e were performed by preparing a sufficiently large sample of paracetamol 
suspension to conduct each set of experiments using the same slurry. This was done in order to investigate 
variability arising from splitting a suspension into sub samples, three replicates of each experiment were 
performed. Experiment 3 was performed to quantify the effect of halting filtration at breakthrough.  
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Off-line filtrate and cake characterization techniques 
Each product filter cake was characterised to assess residual solvent content after drying, purity by UV-vis 
spectrometry and particle size distribution.  The Patent Blue V concentration was selected to achieve a peak 
absorption equal to 1000mAbs to maximise the sensitivity of analysis. This corresponded to a composition of 
around 0.2mL per mL of ethanol when using a 2mm path length cuvette. A zero/baseline correction was applied. 
The main absorption band of Patent Blue V did not overlap with the main paracetamol absorption peak at around 
243nm. A calibration curve was constructed to allow the concentration of the Patent Blue V to be rapidly assessed 
by measuring absorbance at 638nm. 
The blue dye content of the corresponding mother liquors and wash liquors was also determined.  
The extent and strength of agglomeration occurring during static drying was assessed using a cake friability and 
agglomeration test. This evaluation was performed by transferring the product particles to a sieve stack comprising 
1 mm, 500 µm, 250 µm and 180 µm sieves. The sieve column was shaken for 180 seconds using a vortex shaker. 
The mass fraction retained on each sieve was weighed to evaluate the extent of particle agglomeration or breakage. 
The particle size distributions of the dried filter cakes were measured using a Sympatec QICPIC 28 with a Rodos/L 
M4 vibri feeder operating at a feed pressure of 1 bar, a feed rate of 50% and with 1mm gap width.  
The residual wash solvent in the deliquored filter cake was determined by weighing the cake before and after 
drying in a vacuum oven until constant cake mass was attained. 
Results and discussions 
CFD20 optimization 
Several material handling challenges are commonly encountered in manual filtration and washing experiments 
performed with the Biotage system. The approaches to overcoming these using the CFD machine are presented 
below.  
The CFD20 is a continuously operating, automated semi-batch filter which employs dead end filtration that is 
familiar to most prospective operators. It uses commercial BOPP filter media and employs well established 
filtration theory. 14, 29-30 Furthermore it can be coupled with a continuous upstream process and can be located in 
a laboratory fume hood.  
The first obstacle to successful filtration is achieving and maintaining a uniform particle suspension whilst 
transferring this to the filter. Classical manual processing involves swirling the slurry in laboratory glassware and 
pouring the required volume into the filter. Particle settling occurs during decantation of the suspension and leads 
to incomplete solids transfer. As a consequence the solids loading of successive sub-samples increases where the 
first batch dosed from the bulk slurry contains significantly less product than the second and third doses of slurry 
processed. In the context of continuous manufacturing the incoming API suspension will be collected in a stirred 
feed vessel from which aliquots of material will be transferred into the filtration chamber, typically every 180-
300s, depending on the filtration rate. 
A related problem is incomplete recovery of solid material from the glassware. This often requires successive 
back-transfers with the mother liquor to recover all of the particles. An additional consequence of this is that the 
particles in the filter tube settle and form a cake prior to filtration. 
The CFD20 overcomes these issues by automating the suspension sampling and using a vacuum transfer to a 
dosing vessel to load material into the filter. The stirred slurry vessel has appropriate agitation as seen in 
supplementary information sections ensuring particles are uniformly suspended whilst a user defined dose of the 
slurry is transferred, via a dip tube into a dosing vessel located directly above the filter using vacuum transfer. 
The dose is then conveyed to the filter by opening a wide bore pinch valve. Free draining results in an even 
distribution of solids within the glass filter tube. Material holdup is limited by the geometry of the vessel. 
Consistent solid loadings were obtained as the slurry was constantly suspended throughout dispensing. The solid 
transferred was measured by recovering complete suspension samples from the end of the transfer system and 
measuring the loss of mass on drying. The variation in the solids content was typically 1.1% of the total solids 
content. This design of dosing vessel allows the majority of the slurry to transfer with minimal solids lost through 
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adhesion to the walls. By draining from the bottom of the dosing vessel and leaving the valve open during 
filtration, almost all the slurry is transferred to the filtration chamber. Leaving the valve open during filtration also 
helps eliminate dripping from the vessel that cause liquid level disturbance during filtration with consequent 
difficulties for the camera to halt at dry land. 
Another challenge in manual filtration is accurate determination of the end point when halting at dry land, rather 
than breakthrough. This requires precise observation combined with quick and consistent responses from the 
operator. 
The CFD20 employs a vision system to determine the relative heights of the liquid phase and accumulated solids. 
This data is processed in real time using the premise that when dry land is reached both the liquid and solid will 
report the same height. Through processing and filtering the raw image, the measurement can be made robust 
enough to determine the liquid height, even for challenging situations where multiple, indistinct boundaries are 
present. Figure 2 illustrates how the vision system finds the height of the filter cake and liquid separately. The 
blue crosses indicate how as dry land is approached, the two points come closer together before finally meeting 
at the end point (Figure 2).  
 
(a)  
 
 
(b) 
 
 (c)  
 
Figure 2 Schematic of the camera arrangement for the vision system. (a) The camera looks through the side of 
the glass tube (filtration vessel). (b) The liquid and solid interfaces are visible to the camera. (c) The raw 
camera image with the solid/ liquid interface and liquid/ gas interface labelled.The vision system software 
identifies and monitors these two levels to control the filtration end point. 
The next material handling challenge is dosing the required volume of wash solvent onto the top of the filter cake 
without disturbing it. Rapidly adding wash solvent re-suspends the upper layer of the cake causing mother liquor 
back mixing with the wash solvent; it may also cause a thin spot in the cake to form establishing a preferred wash 
pathway further reducing the effectiveness of washing. Manual best practice is to slowly transfer the wash liquid 
running it down the sides of the filter tube using a disposable pipette to minimise cake disturbance. This is not 
implementable in the CFD20 unit so an alternative strategy was devised. The CFD20 uses atomising spray nozzles 
to dispense droplets of around100 µm in diameter. The atomisation also allows the wash solvent to be dispensed 
across the whole surface of the cake and the filter tube walls, assisting in washing the whole cake volume 
efficiently and helping residual particles left on the walls to be washed down onto the cake. 
The final material handling challenge was complete recovery of the deliquored filter cake. In a manual experiment 
the experimentalist must carefully scrape the product from the filter tube with a spatula. The CFD20 carousel 
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positions the filter cake above the point in the base plate which has an opening to the cake discharge tube in place 
of the filter medium located at the other positions. Here a pneumatic piston is used to discharge the filter cake. 
Material losses are limited to a thin layer of product on the wall of the filter tube and a small quantity of dry 
powder escaping around the piston. 
Obtaining reliable data is an essential component in process development allowing process models to be created 
and deepening process understanding. During manual filtration, the times taken to collect specific volumes of 
mother liquor are recorded. This is labour intensive and requires careful attention to detail on the part of the 
experimentalist. The filtrate and spent wash receivers on the CFD rest on individual load cells which are logged 
using Perceptive Engineering Ltd’s PharmaMV software. This allows mass vs time data to be collected during 
each phase of processing for each sample. 
At the end of processing the filter must be cleaned. In the case of manual filtration this involves the experimentalist 
recovering the product and sampling and disposing of the filtrate and spent wash solvent. This brings the potential 
for exposure to APIs which are biologically active. The CFD includes a clean–in-place (CIP) mode in which the 
system is thoroughly cleaned with the cleaning solvent collected in a waste receiver for safe removal and disposal. 
This is a substantial improvement on manual best practice, which relies on engineering controls and personal 
protective equipment to protect the experimentalist. 
 
Filtration rate, cake and media resistance and loss on drying 
The process of dead end filtration is described in the equation first formalised by Darcy, which in its most 
compact and widely used form is shown in equation 1. 29-31 
The volumetric flow rate of the filtrate (𝑑𝑉/ 𝑑𝑡) can be described by:  
𝑑𝑉
𝑑𝑡
=  
𝐴2 ∆𝑃
𝜇 (𝛼𝑐𝑉 + 𝐴𝑅𝑚)
 (1)  
ΔP (kg m-1 s-2) is the pressure drop along the filter axis, A (m2) is the filter area, µ (kg m-1 s-1) is the filtrate 
viscosity, α (m kg-1) the specific cake resistance is related to the cake filterability, Rm (m-1) is the filter medium 
resistance and c (kg m-3) is the dry cake mass per volume filtrate. 
Integrating Equation 1 and rearranging allows α and Rm to be obtained from a t/V versus V plot, as shown in 
Equation 2. α can be calculated by using the gradient of the curve and  Rm the filter medium resistance is calculated 
by using the intercept with the y-axis (Equation 3 and 4). 
𝑡
𝑉
=  
𝜇𝛼𝑐
2𝐴2 ∆𝑃
 𝑉 +  
𝜇 𝑅𝑚
𝐴 ∆𝑃
   (2) 
𝛼 =  
2 𝑔𝑟𝑎𝑑𝑖𝑒𝑛𝑡 𝐴2 ∆𝑃
𝜇 𝑐
   (3) 
𝑅𝑚 =  
𝑖𝑛𝑡𝑒𝑟𝑐𝑒𝑝𝑡 𝐴 ∆𝑃
𝜇
   (4) 
The data analysis is illustrated using data collected during Biotage experiment 2e (micronised paracetamol 
suspended in ethanol and washed with 2 x 10 mL aliquots of Millipore water, see Table 1). This experiment 
exemplifies the characteristic filtration behaviour seen when product particles did not settle significantly before 
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filtration commenced. The V versus t curve shown in 
 
Figure 3(a) reveals how the filtrate flow rate decreased with time. Plotting the corresponding t/V versus V profile 
for micronized paracetamol in  
Figure 3(b) yielded a nearly linear response with a positive slope and a near zero, but fractionally negative 
intercept. The negative intercept is physically unrealistic and may arise from the first time point being collected 
whilst the pressure within the system stabilises and the suspension wets and is drawn into the filter medium. 
Particle size plays a major role in settling as Wakeman et al. report;32 a similar trend is not observed with granular 
material in Figure 6. 
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Figure 3(a) Time versus filtrate volume curve obtained during experiment 2d, filtration of micronized 
paracetamol with Biotage unit. (b) Time/volume versus volume collected during experiment 2d filtration with 
Biotage unit. 
Experiment 3 was conducted with special granular paracetamol suspension using the CFD20. The results 
presented in  
 
Figure 4(a) show an almost constant filtrate flow rate with time. This is consistent with the large paracetamol 
particles having settled to form a low resistance filter cake with an open pore structure before filtration was 
initiated. This phenomenon is described by Stamatakis.18 This outcome was anticipated for the special granular 
material which was selected to challenge the prototype system’s capability to reliably dispense a material where 
the large PSD favoured rapid sedimentation. This results in a virtually constant flow rate and negligible slope of 
the t/V versus V plot, as shown in  
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Figure 4(b), the filtration is very rapid due to the low resistance of the large granular particles, which did not 
increase the resistance to filtrate flow above that of the filter medium.32-35 
 
 
 
 
 
 
 
 
 
Figure 4 (a) Filtrate volume versus time curve obtained during experiment 3 (special granular paracetamol) 
filtration with CFD20 unit. (b) Time/volume versus filtrate volume collected profile obtained during experiment 
3 (special granular paracetamol) filtration with CFD20 unit) 
A similar trend to that seen in the Biotage experiment 2e was observed in CFD20 experiment 4e when processing 
micronized paracetamol. This experiment also showed decreasing filtrate flow rate as cake resistance increased 
during filtration. This can also be observed in Figure 5(a and b). The CFD20 filter medium had an appropriate 
pore size and resistance for the particles to be filtered. 
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Figure 5 (a) Time versus filtrate volume curve obtained during experiment 4e filtration with CFD20 unit (b) 
Time/volume versus filtrate volume collected curve obtained during experiment 4e filtration with CFD20 unit. 
Comparison of Biotage experiments 2d and 2e with CFD 4d and 4e experiments (Table 3) show the same order 
of cake resistance and permeability, although experiments 4d and 4e present slightly higher values. However, a 
big difference is observed in the media resistance. The filter media resistance in the Biotage unit is lower than that 
in the CFD experiments this is consistent with the different materials and construction of the different media.  
 
 
  Table 3 Cake and filter medium resistance values calculated using Darcy's equation to analyse the data collected 
in experiments 2 and 4, conducted using the Biotage and CFD20 systems. 
UNIT EXPERIMENT CAKE 
RESISTANCE (α, 
m/kg) 
MEDIA 
RESISTANCE 
(Rm, m-1) 
PERMEABILITY 
(k, kg/m) 
Biotage 2d(micronized 2 x 5mL 
wash) 
2.22E+09 2.06E+09 4.51E-10 
Biotage 2e(micronized 2 x 
10mL wash) 
2.19E+09 1.04E+08 4.56E-10 
CFD20 4d(micronized 2 x 5mL 
wash) 
9.24E+09 -5.92E+09 1.08E-10 
CFD20 4e(micronized 2 x 
10mL wash) 
5.25E+09 -2.94E+09 1.9E-10 
 
Purity 
The washing performance of the CFD20 and Biotage filtration system were compared by assessing the extent to 
which the soluble impurity, Patent Blue V dye, was removed. Using the extinction coefficient of the patent blue 
dye, the concentration in the mother liquors and each sample of spent wash solvent was calculated from the 
absorbance at 638nm. Combining this with the quantity of liquid recovered at each stage enabled the construction 
of Figure 6 which shows the effectiveness of successive washing steps. 
y = 9.266E+10x + 6.698E+05
R² = 9.879E-01
0.00E+00
5.00E+05
1.00E+06
1.50E+06
2.00E+06
2.50E+06
3.00E+06
3.50E+06
4.00E+06
0.00E+00 1.00E-05 2.00E-05 3.00E-05
Ti
m
e
/ 
vo
lu
m
e
 (
s/
 m
3 )
volume (m3)
0
0.000005
0.00001
0.000015
0.00002
0.000025
0.00003
0 50 100
V
o
lu
m
e
 (
m
3 )
Time (s)
14 
 
 
Figure 6 (a) Normalized patent blue mass removal at each stage in the filtration and washing of special 
granular paracetamol (D = 2 x 5 mL wash, E = 2 x 10 mL wash) f = filtrate, w1 = wash 1, w2 = wash 2, c = 
cake). (b) Normalized patent blue mass removal at each stage in the filtration and washing of micronised 
paracetamol. 
For the granulated paracetamol shown in Figure 6 (a) and micronized paracetamol, Figure 6 (b) the mass of dye 
measured at each stage of washing showed relatively good agreement between the two filtration platforms. As 
expected for a solvent soluble impurity the mass of dye in the filtrate is significantly higher than at any other 
stage. The 10 mL washes (1E) are much more effective than 5 mL washes (1D) in removing the dye. With the 
larger wash volume, less patent blue remained to be removed by the second wash, hence this removed less 
material. The mass of residual patent blue left in the cake was small in all cases. 
The residual dye in the filter cakes is shown in Figure 7.  
  
Figure 7 (a) Normalized residual patent blue mass in filter cakes comparing the CFD and Biotage. (1= 
granular 2 = micronized, d = 2 x 5ml e = 2 x 10 ml). (b) Residual patent blue mass in filter cakes comparing 
filtration to dry land (exp 2)  and breakthrough (exp 4) for micronised paracetamol, b = 1 x 5mL, c = 1 x 10 
mL, d = 2 x 5mL, e = 2 x 10 mL) 
From Figure 7 it is possible to evaluate that washing the cake using two aliquots of 5mL each is more effective 
than using a single dose of 10mL of wash solvent. Washing an impure cake with a bigger aliquot of wash solvent 
and leaving the wash solvent in contact with the impure mother liquor produces a back-mixing effect. The 
prolonged contact of two liquids, one pure and the second that contain impurity produce the mixing of the two 
system with migration of impurity into the pure solvent with consequent reduction of washing efficiency. 
Overall, the CFD20 tended to leave approximately 2 µg more patent blue dye in the filter cake than the Biotage. 
For micronized paracetamol, filtration to breakthrough Figure 7(b) gave much less successful results than halting 
at dry land. When the wash volume was limited to one 5 mL wash, 2-3 times more patent blue was left in the filter 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
1D f 1D
w1
1D
w2
1d c 1E f 1E
w1
1E
w2
1e c
Fr
ac
ti
o
n
al
 o
f 
to
ta
l p
at
e
n
t 
b
lu
e
 
m
as
s
Sample
AWL CFD
Biotage
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
2d f 2d
w1
2d
w2
2d c 2e f 2e
w1
2e
w2
2e c
Fr
ac
ti
o
n
 o
f 
to
ta
l p
at
e
n
t 
b
lu
e
 m
as
s
Sample
AWL CFD
Biotage
0
0.001
0.002
0.003
0.004
0.005
0.006
1d c 1e c 2d c 2e c
Fr
ac
ti
o
n
al
 o
f 
to
ta
l p
at
e
n
t 
b
lu
e
 m
as
s
Experiment
AWL CFD
Biotage
0
0.005
0.01
0.015
0.02
b c d eP
at
e
n
t 
b
lu
e
 r
e
si
d
u
e
 in
 c
ak
e
 (
m
g)
Experiment
exp 2 exp 4
15 
 
cake when filtration continued to breakthrough as opposed to being halted at dry land. For 10 mL washes there 
was less difference in the quantity of blue dye remaining but filtration to dry land still resulted in a purer product 
which is consistent with previous findings.27 
 
Particle size distribution 
The extent of particle agglomeration following washing and drying was quantified using a sequence of test sieves. 
The resulting data are presented in Figure 8. 
 
Figure 8(a) granular paracetamol, CFD20 (first five columns) and Biotage (last two columns) mass fraction 
determined by sieve analysis. (b) Micronized paracetamol, CFD20 (first five columns) and Biotage (last two 
columns) determined by sieving 
Figure 8 (a) shows the effect of different washing strategies on the agglomeration of already granular paracetamol 
(experiment 1). The majority of product particles were retained between the 250 µm and 500 µm sieves which is 
broadly consistent with the starting material (D10 269 µm, D90 466 µm). The data suggest that increasing wash 
quantity from b, (1x 5 mL) to e, (2 x 10 mL) results in increased agglomeration on the CFD system leading to a 
similar result to not washing. This counter-intuitive result can be explained by the effect of back mixing: as 
explained in Figure 7, the prolonged time of contact of impure mother liquor with clean wash solvent bring to 
reduction of washing efficiency. This is not observed with larger wash quantities using the Biotage; 1d = 2 x 5 
mL 1e = 2 x 10 mL. Lump formation or agglomeration arises from incomplete removal of crystallization solvent 
during washing. During the subsequent drying step the trapped residues of crystallization solvent evaporate 
depositing dissolved paracetamol at the points of contact between crystals. The resulting solid bridges between 
crystals cause the particle size to increase due to lump formation or agglomeration. 
The extent of agglomeration of the isolated product arising from filtration, washing and drying of micronized 
paracetamol was also analysed by sieving and the data is shown in Figure 8 (b). Substantial agglomeration took 
place; this was confirmed by particle sizing using the QICPIC. The fraction retained by the 1 mm sieve declines 
with increasing wash quantity indicating the role the quantity of material dissolved in the residual solvent in the 
wet cake plays in agglomeration during static drying. This trend is observed in both CFD20 and Biotage 
experiments. This trend in particle agglomeration is confirmed by QICPIC particle size analysis which 
demonstrates that increasing the number of washes and therefore reducing amount of dye and by implication 
ethanol in cake resulted in the particle size of the isolated material in both the CFD20 and the Biotage equipment 
trending towards, though still some way off the size of the input micronized material. This observation is 
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consistent with the fact that paracetamol is slightly soluble in water and as a result some crystalline bridges 
between particles are likely to be formed on drying. 
Conclusions 
The pharmaceutical industry requires the development of a continuous system capable of filtering, washing and 
drying crystallised APIs. Such a system has been prototyped in collaboration with Alconbury Weston Ltd to 
produce a continuous filtration and drying unit called the CFD20. This work has identified key performance 
measures and developed some testing methodologies to evaluate device performance. The CFD20, as a prototype 
continuous filtration, washing and drying unit, was tested against the obvious success criteria of; achieving 
comparable cake purity at the end of isolation with respect to the Biotage unit, delivering and unaltered product 
PSD consistent with the material produced by crystallization and achieving the flexibility and simple operability 
of the Biotage system but with enhanced control and automated data collection. 
Key challenges of suspending material uniformly, transferring a representative sub sample to a filtration chamber, 
halting filtration at an appropriate point and recovering the filtered material were identified. These challenges 
were evaluated using a manual system representative of current best practice in pharmaceutical process 
development and compared to the solutions embodied in the CFD20. In each area, the CFD20 performed 
comparably well, if not better, than manual best practice.  
Comparing the filtration performance of the approaches, the parameters derived from Darcy’s law showed good 
agreement. Automated data collection supports improved understanding of filtration process development. 
Wash performance was evaluated by the removal of patent blue V from two very different filter cakes prepared 
from micronised and granular paracetamol. Overall the performance of the units was similar. 
Particle damage or agglomeration was assessed by sieving the isolated product; both platforms caused 
considerable changes in particle size after filtering and washing which is consistent with industrial experience. 
Micronized particles showed a substantial increase in size caused by agglomeration. Careful washing of the 
micronized powder caused some reduction in the extent of formation of very large agglomerates but the filtered 
washed and dried material did not recover the same particle size distribution as the feed material. Back-mixing of 
mother liquor and wash solvent is responsible of reduction of cake purity and enhance of agglomeration in AWL 
experiments (see Figure 7 and 8). 
This work has shown the potential for an automated solution to address challenges encountered in manual 
filtration, washing and drying processes and indicates how automation can facilitate continuous isolation. The 
CFD20 performed comparably well with the Biotage system, and required much less manual intervention and 
material handling. In future work operation with more challenging materials will be evaluated including the 
removal of structurally related impurities and filtration of traditionally hard to filter crystals with plate-like and 
needle like habits. Automating and repeatedly operating batch isolation provides a platform for systematic process 
development and optimisation; linking this with a predictive model of filterability will support rapid determination 
of filtration parameters for new materials. Scale up to continuous operation then represents lower risk compared 
to classical continuous plant, which has very different characteristics to manual laboratory process development 
or to current batch operations.  
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